Research Articles | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
The Advancing Landscape of Paroxysmal Nocturnal Hemoglobinuria Treatment May 2025 Turkish Journal of Haematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
Where There's Smoke, There's Fire: Inflammation Drives MDS Jul 2020 Trends in immunology Myelodysplastic Syndromes (MDS)
Transplant Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care Apr 2023 Transplantation and Cellular Therapy Myelodysplastic Syndromes (MDS)
Allogeneic Hematopoietic Cell Transplantation for the Treatment of Severe Aplastic Anemia: Evidence-Based Guidelines From the American Society for Transplantation and Cellular Therapy Sep 2024 Transplantation and Cellular Therapy Myelodysplastic Syndromes (MDS)
Transplantation Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care Jul 2023 Transplantation and Cellular Therapy Myelodysplastic Syndromes (MDS)
Epigenetic Aging and Hematopoietic Cell Transplantation in Patients With Severe Aplastic Anemia Apr 2021 Transplantation and Cellular Therapy Aplastic Anemia, Graft Versus Host Disease (GVHD)
Management of myelodysplastic syndromes after failure of response to hypomethylating agents May 2019 Therapeutic Advances in Hematology Myelodysplastic Syndromes (MDS)
Current landscape of paroxysmal nocturnal hemoglobinuria in the era of complement inhibitors and regulators Dec 2024 Therapeutic Advances in Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
Treatment options for lower-risk myelodysplastic syndromes. Where are we now? Jan 2021 Therapeutic Advances in Hematology Myelodysplastic Syndromes (MDS)
Efficacy of complement inhibitors for patients with paroxysmal nocturnal hemoglobinuria: a systematic review and meta-analysis Dec 2023 Therapeutic Advances in Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)